Health ❯Healthcare

Biotechnology

Gene Therapy Gene Editing Clinical Trials Drug Development Therapeutics Cancer Treatment Immuno-Oncology Vaccine Development Diagnostic Tests Pharmaceuticals

Sarepta Defies FDA Order to Halt Elevidys After Third Patient Death

The FDA paused clinical trials after three liver-failure deaths linked to the Duchenne gene therapy.

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

Regencell Shares Soar to $36 Billion Valuation Despite Zero Revenue

Eli Lilly to Acquire Verve Therapeutics as Gene-Editing Trial Begins

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Anne Wojcicki’s Nonprofit Wins Bid to Acquire 23andMe for $305 Million

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

Lotte Biologics Secures First ADC Manufacturing Deal, Launches Full-Scale Operations

Verve-102 Gene-Editing Therapy Shows Promising LDL Cholesterol Reduction in Early Trial

France Expands Endometriosis Initiatives with Saliva-Based Diagnostic Test and Awareness Campaigns

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Second Successful Pig Kidney Transplant Offers New Hope for Organ Shortage Crisis

UK Biobank Launches Largest Proteomics Study to Transform Disease Research